ENDPOINTS

Exclusive: ProteinQure raises $11M Series A for peptide drugs

When Lucas Siow and his three fellow co-founders started ProteinQure in 2017, they had nine years of combined work experience, and Siow accounted for seven of those years. The hard lessons came early for the ...

May 27, 2025 - 12:04
 0
Exclusive: ProteinQure raises $11M Series A for peptide drugs
When Lucas Siow and his three fellow co-founders started ProteinQure in 2017, they had nine years of combined work experience, and Siow accounted for seven of those years. The hard lessons came early for the ...
Read More

Tags:

Previous Article

Syndeio debuts with $90M+ to bring together synapse repair drugs

Next Article

Prothena’s amyloidosis drug flops again, spending and staff cuts are on the way

Related Posts

Biogen taps City Therapeutics in RNAi deal worth up to $1B

Biogen taps City Therapeutics in RNAi deal worth up to $1B

May 27, 2025  0

Sanofi touts $20B investment in US over five years

Sanofi touts $20B investment in US over five years

May 14, 2025  0

Will the FDA approve Moderna's next-gen Covid shot?

Will the FDA approve Moderna's next-gen Covid shot?

May 28, 2025  0